Daiken Medical Co., Ltd. provided consolidated earnings guidance for the Six months ending September 30, 2023 and full year ending March 31, 2024. For the period, the company expects net sales of JPY 4,650 million, operating profit of JPY 550 million, profit of JPY 380 million and basic earnings per share of JPY 13.23.

For the year, the company expects net sales of JPY 9,600 million, operating profit of JPY 1,300 million, profit of JPY 900 million and basic earnings per share of JPY 31.33.